CURCUMIN AND DIABETES: MECHANISMS OF ACTION AND ITS ANTI-DIABETIC PROPERTIES
暂无分享,去创建一个
[1] Bin Zhang,et al. Curcumin ameliorated diabetic neuropathy partially by inhibition of NADPH oxidase mediating oxidative stress in the spinal cord , 2014, Neuroscience Letters.
[2] H. Banafshe,et al. Effect of curcumin on diabetic peripheral neuropathic pain: possible involvement of opioid system. , 2014, European journal of pharmacology.
[3] S. Aly,et al. Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways. , 2013, International journal of physiology, pathophysiology and pharmacology.
[4] S. Mahfouz,et al. The effect of a novel curcumin derivative on pancreatic islet regeneration in experimental type-1 diabetes in rats (long term study) , 2013, Diabetology & Metabolic Syndrome.
[5] Jun-Li Liu,et al. Curcumin and Diabetes: A Systematic Review , 2013, Evidence-based complementary and alternative medicine : eCAM.
[6] G. Manda,et al. Membranar effects exerted in vitro by polyphenols - quercetin, epigallocatechin gallate and curcumin - on HUVEC and Jurkat cells, relevant for diabetes mellitus. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[7] N. Balakrishna,et al. Efficacy of Biodegradable Curcumin Nanoparticles in Delaying Cataract in Diabetic Rat Model , 2013, PloS one.
[8] Hansongyi Lee,et al. Obesity, Inflammation and Diet , 2013, Pediatric gastroenterology, hepatology & nutrition.
[9] A. Bansal,et al. SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for neuroprotection. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[10] T. Tsuda,et al. Curcumin stimulates glucagon-like peptide-1 secretion in GLUTag cells via Ca2+/calmodulin-dependent kinase II activation. , 2013, Biochemical and biophysical research communications.
[11] Kenji Suzuki,et al. Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats. , 2013, The Journal of nutritional biochemistry.
[12] Maria Cekanova,et al. Modulation of adipose tissue inflammation by bioactive food compounds. , 2013, The Journal of nutritional biochemistry.
[13] Ashok Balasubramanyam,et al. The Role of the Immune System in Obesity and Insulin Resistance , 2013, Journal of obesity.
[14] S. Ryter,et al. Curcumin induces apoptotic cell death of activated human CD4+ T cells via increasing endoplasmic reticulum stress and mitochondrial dysfunction. , 2013, International immunopharmacology.
[15] De-bao Liu,et al. Curcumin Attenuates Diabetic Neuropathic Pain by Downregulating TNF-α in a Rat Model , 2013, International journal of medical sciences.
[16] Peiqing Liu,et al. Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway , 2013, Molecular and Cellular Endocrinology.
[17] Chao Liu,et al. Curcumin Alleviates Diabetic Cardiomyopathy in Experimental Diabetic Rats , 2012, PloS one.
[18] M. Nagata,et al. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[19] P. Salimath,et al. Effect of curcumin and quercetin on lysosomal enzyme activities in streptozotocin-induced diabetic rats. , 2012, Clinical nutrition.
[20] C. Chyau,et al. Trapping of methylglyoxal by curcumin in cell-free systems and in human umbilical vein endothelial cells. , 2012, Journal of agricultural and food chemistry.
[21] Jianguo Lin,et al. Curcumin inhibits gene expression of receptor for advanced glycation end‐products (RAGE) in hepatic stellate cells in vitro by elevating PPARγ activity and attenuating oxidative stress , 2012, British journal of pharmacology.
[22] Samuel Sparks,et al. Curcumin modulates the self-assembly of the islet amyloid polypeptide by disassembling α-helix. , 2012, Biochemical and biophysical research communications.
[23] Jianguo Lin,et al. Curcumin eliminates the inhibitory effect of advanced glycation end-products (AGEs) on gene expression of AGE receptor-1 in hepatic stellate cells in vitro , 2012, Laboratory Investigation.
[24] Kenji Suzuki,et al. Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats. , 2011, Molecular nutrition & food research.
[25] K. Javidnia,et al. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: A randomized, double-blind and placebo-controlled study , 2011, Scandinavian journal of urology and nephrology.
[26] Kenji Suzuki,et al. Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy , 2011, Nutrition & metabolism.
[27] N. Škalko-Basnet,et al. Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment , 2011, Molecules.
[28] Xiaolong Liu,et al. MCP-1 Upregulates Amylin Expression in Murine Pancreatic β Cells through ERK/JNK-AP1 and NF-κB Related Signaling Pathways Independent of CCR2 , 2011, PloS one.
[29] W. Xie,et al. Diabetes is an inflammatory disease: evidence from traditional Chinese medicines , 2011, Diabetes, obesity & metabolism.
[30] G. Appendino,et al. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. , 2011, Journal of natural products.
[31] Naijil George,et al. Role of curcumin in the prevention of cholinergic mediated cortical dysfunctions in streptozotocin-induced diabetic rats , 2011, Molecular and Cellular Endocrinology.
[32] G. Belcaro,et al. Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. , 2010, Alternative medicine review : a journal of clinical therapeutic.
[33] G. Maru,et al. Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. , 2010, Journal of agricultural and food chemistry.
[34] S. Joyal,et al. A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95®CG (Biocurcumax™), A Novel Bioenhanced Preparation of Curcumin , 2008, Indian journal of pharmaceutical sciences.
[35] Robert A Newman,et al. Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.
[36] M. Majeed,et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. , 1998, Planta medica.
[37] A. Shehzad,et al. Curcumin in inflammatory diseases , 2013, BioFactors.